Global Non-recombinant Coagulation Factors Supply, Demand and Key Producers, 2023-2029

Publisher Name :
Date: 08-Dec-2023
No. of pages: 146

The global Non-recombinant Coagulation Factors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.

This report studies the global Non-recombinant Coagulation Factors production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Non-recombinant Coagulation Factors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-recombinant Coagulation Factors that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Non-recombinant Coagulation Factors total production and demand, 2018-2029, (K Units)

Global Non-recombinant Coagulation Factors total production value, 2018-2029, (USD Million)

Global Non-recombinant Coagulation Factors production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Non-recombinant Coagulation Factors consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Non-recombinant Coagulation Factors domestic production, consumption, key domestic manufacturers and share

Global Non-recombinant Coagulation Factors production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Non-recombinant Coagulation Factors production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Non-recombinant Coagulation Factors production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Non-recombinant Coagulation Factors market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical, Instituto Grifols SA, CSL Behring LLC, KM Biologics KK, Baxter Healthcare Corp., Sanquin, Johnson & Johnson, Octapharma AG and Bio Products Laboratory Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-recombinant Coagulation Factors market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Non-recombinant Coagulation Factors Market, By Region:

- United States

- China

- Europe

- Japan

- South Korea

- ASEAN

- India

- Rest of World

Global Non-recombinant Coagulation Factors Market, Segmentation by Type

- Coagulation Factor VIII

- Human Fibrinogen

- Others

Global Non-recombinant Coagulation Factors Market, Segmentation by Application

- Hemophilia

- Fibrinogen Deficiency

- Other

Companies Profiled:

- Takeda Pharmaceutical

- Instituto Grifols SA

- CSL Behring LLC

- KM Biologics KK

- Baxter Healthcare Corp.

- Sanquin

- Johnson & Johnson

- Octapharma AG

- Bio Products Laboratory Ltd.

- Grifols Biologicals, Inc.

- Pfizer Inc.

- Intas Biopharmaceuticals Ltd.

- Shandong Taibang Biological Products

- Sinopharm Group Shanghai Blood Products

- SHANGHAI RAAS

- China Resources Boya Bio-Pharmaceutical

- Chengdu Rongsheng Pharmaceuticals

- Yuanda Shuyang Pharmaceutical

- HUALAN BIO

Key Questions Answered

1. How big is the global Non-recombinant Coagulation Factors market?

2. What is the demand of the global Non-recombinant Coagulation Factors market?

3. What is the year over year growth of the global Non-recombinant Coagulation Factors market?

4. What is the production and production value of the global Non-recombinant Coagulation Factors market?

5. Who are the key producers in the global Non-recombinant Coagulation Factors market?

Global Non-recombinant Coagulation Factors Supply, Demand and Key Producers, 2023-2029

Table of Contents

1 Supply Summary
1.1 Non-recombinant Coagulation Factors Introduction
1.2 World Non-recombinant Coagulation Factors Supply & Forecast
1.2.1 World Non-recombinant Coagulation Factors Production Value (2018 & 2022 & 2029)
1.2.2 World Non-recombinant Coagulation Factors Production (2018-2029)
1.2.3 World Non-recombinant Coagulation Factors Pricing Trends (2018-2029)
1.3 World Non-recombinant Coagulation Factors Production by Region (Based on Production Site)
1.3.1 World Non-recombinant Coagulation Factors Production Value by Region (2018-2029)
1.3.2 World Non-recombinant Coagulation Factors Production by Region (2018-2029)
1.3.3 World Non-recombinant Coagulation Factors Average Price by Region (2018-2029)
1.3.4 North America Non-recombinant Coagulation Factors Production (2018-2029)
1.3.5 Europe Non-recombinant Coagulation Factors Production (2018-2029)
1.3.6 China Non-recombinant Coagulation Factors Production (2018-2029)
1.3.7 Japan Non-recombinant Coagulation Factors Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-recombinant Coagulation Factors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-recombinant Coagulation Factors Major Market Trends
2 Demand Summary
2.1 World Non-recombinant Coagulation Factors Demand (2018-2029)
2.2 World Non-recombinant Coagulation Factors Consumption by Region
2.2.1 World Non-recombinant Coagulation Factors Consumption by Region (2018-2023)
2.2.2 World Non-recombinant Coagulation Factors Consumption Forecast by Region (2024-2029)
2.3 United States Non-recombinant Coagulation Factors Consumption (2018-2029)
2.4 China Non-recombinant Coagulation Factors Consumption (2018-2029)
2.5 Europe Non-recombinant Coagulation Factors Consumption (2018-2029)
2.6 Japan Non-recombinant Coagulation Factors Consumption (2018-2029)
2.7 South Korea Non-recombinant Coagulation Factors Consumption (2018-2029)
2.8 ASEAN Non-recombinant Coagulation Factors Consumption (2018-2029)
2.9 India Non-recombinant Coagulation Factors Consumption (2018-2029)
3 World Non-recombinant Coagulation Factors Manufacturers Competitive Analysis
3.1 World Non-recombinant Coagulation Factors Production Value by Manufacturer (2018-2023)
3.2 World Non-recombinant Coagulation Factors Production by Manufacturer (2018-2023)
3.3 World Non-recombinant Coagulation Factors Average Price by Manufacturer (2018-2023)
3.4 Non-recombinant Coagulation Factors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non-recombinant Coagulation Factors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non-recombinant Coagulation Factors in 2022
3.5.3 Global Concentration Ratios (CR8) for Non-recombinant Coagulation Factors in 2022
3.6 Non-recombinant Coagulation Factors Market: Overall Company Footprint Analysis
3.6.1 Non-recombinant Coagulation Factors Market: Region Footprint
3.6.2 Non-recombinant Coagulation Factors Market: Company Product Type Footprint
3.6.3 Non-recombinant Coagulation Factors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Non-recombinant Coagulation Factors Production Value Comparison
4.1.1 United States VS China: Non-recombinant Coagulation Factors Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Non-recombinant Coagulation Factors Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Non-recombinant Coagulation Factors Production Comparison
4.2.1 United States VS China: Non-recombinant Coagulation Factors Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non-recombinant Coagulation Factors Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Non-recombinant Coagulation Factors Consumption Comparison
4.3.1 United States VS China: Non-recombinant Coagulation Factors Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Non-recombinant Coagulation Factors Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Non-recombinant Coagulation Factors Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Non-recombinant Coagulation Factors Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Non-recombinant Coagulation Factors Production Value (2018-2023)
4.4.3 United States Based Manufacturers Non-recombinant Coagulation Factors Production (2018-2023)
4.5 China Based Non-recombinant Coagulation Factors Manufacturers and Market Share
4.5.1 China Based Non-recombinant Coagulation Factors Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Non-recombinant Coagulation Factors Production Value (2018-2023)
4.5.3 China Based Manufacturers Non-recombinant Coagulation Factors Production (2018-2023)
4.6 Rest of World Based Non-recombinant Coagulation Factors Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Non-recombinant Coagulation Factors Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Non-recombinant Coagulation Factors Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Non-recombinant Coagulation Factors Production (2018-2023)
5 Market Analysis by Type
5.1 World Non-recombinant Coagulation Factors Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Coagulation Factor VIII
5.2.2 Human Fibrinogen
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Non-recombinant Coagulation Factors Production by Type (2018-2029)
5.3.2 World Non-recombinant Coagulation Factors Production Value by Type (2018-2029)
5.3.3 World Non-recombinant Coagulation Factors Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Non-recombinant Coagulation Factors Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hemophilia
6.2.2 Fibrinogen Deficiency
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Non-recombinant Coagulation Factors Production by Application (2018-2029)
6.3.2 World Non-recombinant Coagulation Factors Production Value by Application (2018-2029)
6.3.3 World Non-recombinant Coagulation Factors Average Price by Application (2018-2029)
7 Company Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Details
7.1.2 Takeda Pharmaceutical Major Business
7.1.3 Takeda Pharmaceutical Non-recombinant Coagulation Factors Product and Services
7.1.4 Takeda Pharmaceutical Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Takeda Pharmaceutical Recent Developments/Updates
7.1.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.2 Instituto Grifols SA
7.2.1 Instituto Grifols SA Details
7.2.2 Instituto Grifols SA Major Business
7.2.3 Instituto Grifols SA Non-recombinant Coagulation Factors Product and Services
7.2.4 Instituto Grifols SA Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Instituto Grifols SA Recent Developments/Updates
7.2.6 Instituto Grifols SA Competitive Strengths & Weaknesses
7.3 CSL Behring LLC
7.3.1 CSL Behring LLC Details
7.3.2 CSL Behring LLC Major Business
7.3.3 CSL Behring LLC Non-recombinant Coagulation Factors Product and Services
7.3.4 CSL Behring LLC Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CSL Behring LLC Recent Developments/Updates
7.3.6 CSL Behring LLC Competitive Strengths & Weaknesses
7.4 KM Biologics KK
7.4.1 KM Biologics KK Details
7.4.2 KM Biologics KK Major Business
7.4.3 KM Biologics KK Non-recombinant Coagulation Factors Product and Services
7.4.4 KM Biologics KK Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 KM Biologics KK Recent Developments/Updates
7.4.6 KM Biologics KK Competitive Strengths & Weaknesses
7.5 Baxter Healthcare Corp.
7.5.1 Baxter Healthcare Corp. Details
7.5.2 Baxter Healthcare Corp. Major Business
7.5.3 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product and Services
7.5.4 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Baxter Healthcare Corp. Recent Developments/Updates
7.5.6 Baxter Healthcare Corp. Competitive Strengths & Weaknesses
7.6 Sanquin
7.6.1 Sanquin Details
7.6.2 Sanquin Major Business
7.6.3 Sanquin Non-recombinant Coagulation Factors Product and Services
7.6.4 Sanquin Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sanquin Recent Developments/Updates
7.6.6 Sanquin Competitive Strengths & Weaknesses
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Details
7.7.2 Johnson & Johnson Major Business
7.7.3 Johnson & Johnson Non-recombinant Coagulation Factors Product and Services
7.7.4 Johnson & Johnson Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Johnson & Johnson Recent Developments/Updates
7.7.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.8 Octapharma AG
7.8.1 Octapharma AG Details
7.8.2 Octapharma AG Major Business
7.8.3 Octapharma AG Non-recombinant Coagulation Factors Product and Services
7.8.4 Octapharma AG Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Octapharma AG Recent Developments/Updates
7.8.6 Octapharma AG Competitive Strengths & Weaknesses
7.9 Bio Products Laboratory Ltd.
7.9.1 Bio Products Laboratory Ltd. Details
7.9.2 Bio Products Laboratory Ltd. Major Business
7.9.3 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product and Services
7.9.4 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Bio Products Laboratory Ltd. Recent Developments/Updates
7.9.6 Bio Products Laboratory Ltd. Competitive Strengths & Weaknesses
7.10 Grifols Biologicals, Inc.
7.10.1 Grifols Biologicals, Inc. Details
7.10.2 Grifols Biologicals, Inc. Major Business
7.10.3 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product and Services
7.10.4 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Grifols Biologicals, Inc. Recent Developments/Updates
7.10.6 Grifols Biologicals, Inc. Competitive Strengths & Weaknesses
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Details
7.11.2 Pfizer Inc. Major Business
7.11.3 Pfizer Inc. Non-recombinant Coagulation Factors Product and Services
7.11.4 Pfizer Inc. Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Pfizer Inc. Recent Developments/Updates
7.11.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.12 Intas Biopharmaceuticals Ltd.
7.12.1 Intas Biopharmaceuticals Ltd. Details
7.12.2 Intas Biopharmaceuticals Ltd. Major Business
7.12.3 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product and Services
7.12.4 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Intas Biopharmaceuticals Ltd. Recent Developments/Updates
7.12.6 Intas Biopharmaceuticals Ltd. Competitive Strengths & Weaknesses
7.13 Shandong Taibang Biological Products
7.13.1 Shandong Taibang Biological Products Details
7.13.2 Shandong Taibang Biological Products Major Business
7.13.3 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product and Services
7.13.4 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Shandong Taibang Biological Products Recent Developments/Updates
7.13.6 Shandong Taibang Biological Products Competitive Strengths & Weaknesses
7.14 Sinopharm Group Shanghai Blood Products
7.14.1 Sinopharm Group Shanghai Blood Products Details
7.14.2 Sinopharm Group Shanghai Blood Products Major Business
7.14.3 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product and Services
7.14.4 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Sinopharm Group Shanghai Blood Products Recent Developments/Updates
7.14.6 Sinopharm Group Shanghai Blood Products Competitive Strengths & Weaknesses
7.15 SHANGHAI RAAS
7.15.1 SHANGHAI RAAS Details
7.15.2 SHANGHAI RAAS Major Business
7.15.3 SHANGHAI RAAS Non-recombinant Coagulation Factors Product and Services
7.15.4 SHANGHAI RAAS Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 SHANGHAI RAAS Recent Developments/Updates
7.15.6 SHANGHAI RAAS Competitive Strengths & Weaknesses
7.16 China Resources Boya Bio-Pharmaceutical
7.16.1 China Resources Boya Bio-Pharmaceutical Details
7.16.2 China Resources Boya Bio-Pharmaceutical Major Business
7.16.3 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product and Services
7.16.4 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 China Resources Boya Bio-Pharmaceutical Recent Developments/Updates
7.16.6 China Resources Boya Bio-Pharmaceutical Competitive Strengths & Weaknesses
7.17 Chengdu Rongsheng Pharmaceuticals
7.17.1 Chengdu Rongsheng Pharmaceuticals Details
7.17.2 Chengdu Rongsheng Pharmaceuticals Major Business
7.17.3 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product and Services
7.17.4 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Chengdu Rongsheng Pharmaceuticals Recent Developments/Updates
7.17.6 Chengdu Rongsheng Pharmaceuticals Competitive Strengths & Weaknesses
7.18 Yuanda Shuyang Pharmaceutical
7.18.1 Yuanda Shuyang Pharmaceutical Details
7.18.2 Yuanda Shuyang Pharmaceutical Major Business
7.18.3 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product and Services
7.18.4 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Yuanda Shuyang Pharmaceutical Recent Developments/Updates
7.18.6 Yuanda Shuyang Pharmaceutical Competitive Strengths & Weaknesses
7.19 HUALAN BIO
7.19.1 HUALAN BIO Details
7.19.2 HUALAN BIO Major Business
7.19.3 HUALAN BIO Non-recombinant Coagulation Factors Product and Services
7.19.4 HUALAN BIO Non-recombinant Coagulation Factors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 HUALAN BIO Recent Developments/Updates
7.19.6 HUALAN BIO Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Non-recombinant Coagulation Factors Industry Chain
8.2 Non-recombinant Coagulation Factors Upstream Analysis
8.2.1 Non-recombinant Coagulation Factors Core Raw Materials
8.2.2 Main Manufacturers of Non-recombinant Coagulation Factors Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Non-recombinant Coagulation Factors Production Mode
8.6 Non-recombinant Coagulation Factors Procurement Model
8.7 Non-recombinant Coagulation Factors Industry Sales Model and Sales Channels
8.7.1 Non-recombinant Coagulation Factors Sales Model
8.7.2 Non-recombinant Coagulation Factors Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List of Tables
Table 1. World Non-recombinant Coagulation Factors Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Non-recombinant Coagulation Factors Production Value by Region (2018-2023) & (USD Million)
Table 3. World Non-recombinant Coagulation Factors Production Value by Region (2024-2029) & (USD Million)
Table 4. World Non-recombinant Coagulation Factors Production Value Market Share by Region (2018-2023)
Table 5. World Non-recombinant Coagulation Factors Production Value Market Share by Region (2024-2029)
Table 6. World Non-recombinant Coagulation Factors Production by Region (2018-2023) & (K Units)
Table 7. World Non-recombinant Coagulation Factors Production by Region (2024-2029) & (K Units)
Table 8. World Non-recombinant Coagulation Factors Production Market Share by Region (2018-2023)
Table 9. World Non-recombinant Coagulation Factors Production Market Share by Region (2024-2029)
Table 10. World Non-recombinant Coagulation Factors Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Non-recombinant Coagulation Factors Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Non-recombinant Coagulation Factors Major Market Trends
Table 13. World Non-recombinant Coagulation Factors Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Non-recombinant Coagulation Factors Consumption by Region (2018-2023) & (K Units)
Table 15. World Non-recombinant Coagulation Factors Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Non-recombinant Coagulation Factors Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Non-recombinant Coagulation Factors Producers in 2022
Table 18. World Non-recombinant Coagulation Factors Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Non-recombinant Coagulation Factors Producers in 2022
Table 20. World Non-recombinant Coagulation Factors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Non-recombinant Coagulation Factors Company Evaluation Quadrant
Table 22. World Non-recombinant Coagulation Factors Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Non-recombinant Coagulation Factors Production Site of Key Manufacturer
Table 24. Non-recombinant Coagulation Factors Market: Company Product Type Footprint
Table 25. Non-recombinant Coagulation Factors Market: Company Product Application Footprint
Table 26. Non-recombinant Coagulation Factors Competitive Factors
Table 27. Non-recombinant Coagulation Factors New Entrant and Capacity Expansion Plans
Table 28. Non-recombinant Coagulation Factors Mergers & Acquisitions Activity
Table 29. United States VS China Non-recombinant Coagulation Factors Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Non-recombinant Coagulation Factors Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Non-recombinant Coagulation Factors Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Non-recombinant Coagulation Factors Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Non-recombinant Coagulation Factors Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Non-recombinant Coagulation Factors Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Non-recombinant Coagulation Factors Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Non-recombinant Coagulation Factors Production Market Share (2018-2023)
Table 37. China Based Non-recombinant Coagulation Factors Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Non-recombinant Coagulation Factors Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Non-recombinant Coagulation Factors Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Non-recombinant Coagulation Factors Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Non-recombinant Coagulation Factors Production Market Share (2018-2023)
Table 42. Rest of World Based Non-recombinant Coagulation Factors Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Non-recombinant Coagulation Factors Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Non-recombinant Coagulation Factors Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Non-recombinant Coagulation Factors Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Non-recombinant Coagulation Factors Production Market Share (2018-2023)
Table 47. World Non-recombinant Coagulation Factors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Non-recombinant Coagulation Factors Production by Type (2018-2023) & (K Units)
Table 49. World Non-recombinant Coagulation Factors Production by Type (2024-2029) & (K Units)
Table 50. World Non-recombinant Coagulation Factors Production Value by Type (2018-2023) & (USD Million)
Table 51. World Non-recombinant Coagulation Factors Production Value by Type (2024-2029) & (USD Million)
Table 52. World Non-recombinant Coagulation Factors Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Non-recombinant Coagulation Factors Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Non-recombinant Coagulation Factors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Non-recombinant Coagulation Factors Production by Application (2018-2023) & (K Units)
Table 56. World Non-recombinant Coagulation Factors Production by Application (2024-2029) & (K Units)
Table 57. World Non-recombinant Coagulation Factors Production Value by Application (2018-2023) & (USD Million)
Table 58. World Non-recombinant Coagulation Factors Production Value by Application (2024-2029) & (USD Million)
Table 59. World Non-recombinant Coagulation Factors Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Non-recombinant Coagulation Factors Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Pharmaceutical Major Business
Table 63. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product and Services
Table 64. Takeda Pharmaceutical Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Takeda Pharmaceutical Recent Developments/Updates
Table 66. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Instituto Grifols SA Basic Information, Manufacturing Base and Competitors
Table 68. Instituto Grifols SA Major Business
Table 69. Instituto Grifols SA Non-recombinant Coagulation Factors Product and Services
Table 70. Instituto Grifols SA Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Instituto Grifols SA Recent Developments/Updates
Table 72. Instituto Grifols SA Competitive Strengths & Weaknesses
Table 73. CSL Behring LLC Basic Information, Manufacturing Base and Competitors
Table 74. CSL Behring LLC Major Business
Table 75. CSL Behring LLC Non-recombinant Coagulation Factors Product and Services
Table 76. CSL Behring LLC Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CSL Behring LLC Recent Developments/Updates
Table 78. CSL Behring LLC Competitive Strengths & Weaknesses
Table 79. KM Biologics KK Basic Information, Manufacturing Base and Competitors
Table 80. KM Biologics KK Major Business
Table 81. KM Biologics KK Non-recombinant Coagulation Factors Product and Services
Table 82. KM Biologics KK Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. KM Biologics KK Recent Developments/Updates
Table 84. KM Biologics KK Competitive Strengths & Weaknesses
Table 85. Baxter Healthcare Corp. Basic Information, Manufacturing Base and Competitors
Table 86. Baxter Healthcare Corp. Major Business
Table 87. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product and Services
Table 88. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Baxter Healthcare Corp. Recent Developments/Updates
Table 90. Baxter Healthcare Corp. Competitive Strengths & Weaknesses
Table 91. Sanquin Basic Information, Manufacturing Base and Competitors
Table 92. Sanquin Major Business
Table 93. Sanquin Non-recombinant Coagulation Factors Product and Services
Table 94. Sanquin Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sanquin Recent Developments/Updates
Table 96. Sanquin Competitive Strengths & Weaknesses
Table 97. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 98. Johnson & Johnson Major Business
Table 99. Johnson & Johnson Non-recombinant Coagulation Factors Product and Services
Table 100. Johnson & Johnson Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Johnson & Johnson Recent Developments/Updates
Table 102. Johnson & Johnson Competitive Strengths & Weaknesses
Table 103. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 104. Octapharma AG Major Business
Table 105. Octapharma AG Non-recombinant Coagulation Factors Product and Services
Table 106. Octapharma AG Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Octapharma AG Recent Developments/Updates
Table 108. Octapharma AG Competitive Strengths & Weaknesses
Table 109. Bio Products Laboratory Ltd. Basic Information, Manufacturing Base and Competitors
Table 110. Bio Products Laboratory Ltd. Major Business
Table 111. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product and Services
Table 112. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Bio Products Laboratory Ltd. Recent Developments/Updates
Table 114. Bio Products Laboratory Ltd. Competitive Strengths & Weaknesses
Table 115. Grifols Biologicals, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Grifols Biologicals, Inc. Major Business
Table 117. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product and Services
Table 118. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Grifols Biologicals, Inc. Recent Developments/Updates
Table 120. Grifols Biologicals, Inc. Competitive Strengths & Weaknesses
Table 121. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Pfizer Inc. Major Business
Table 123. Pfizer Inc. Non-recombinant Coagulation Factors Product and Services
Table 124. Pfizer Inc. Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Pfizer Inc. Recent Developments/Updates
Table 126. Pfizer Inc. Competitive Strengths & Weaknesses
Table 127. Intas Biopharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Intas Biopharmaceuticals Ltd. Major Business
Table 129. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product and Services
Table 130. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Intas Biopharmaceuticals Ltd. Recent Developments/Updates
Table 132. Intas Biopharmaceuticals Ltd. Competitive Strengths & Weaknesses
Table 133. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 134. Shandong Taibang Biological Products Major Business
Table 135. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product and Services
Table 136. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Shandong Taibang Biological Products Recent Developments/Updates
Table 138. Shandong Taibang Biological Products Competitive Strengths & Weaknesses
Table 139. Sinopharm Group Shanghai Blood Products Basic Information, Manufacturing Base and Competitors
Table 140. Sinopharm Group Shanghai Blood Products Major Business
Table 141. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product and Services
Table 142. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Sinopharm Group Shanghai Blood Products Recent Developments/Updates
Table 144. Sinopharm Group Shanghai Blood Products Competitive Strengths & Weaknesses
Table 145. SHANGHAI RAAS Basic Information, Manufacturing Base and Competitors
Table 146. SHANGHAI RAAS Major Business
Table 147. SHANGHAI RAAS Non-recombinant Coagulation Factors Product and Services
Table 148. SHANGHAI RAAS Non-recombinan
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs